Rifeson Tablets 50mg (Eperisone Hydrochloride)

Adult dose

As Eperisone Hydrochloride, 50 mg is taken orally after meals three times a day. Adjust as appropriate based on age and symptoms.

This medication should not be used in certain patients. First, patients who have had an allergic reaction to this medication should not take it. Also, patients with myasthenia gravis should not take this medication. Since this medication contains lactose, patients with genetic disorders that prevent lactose digestion should not take it. Caution is required when using this medication. Patients with a history of drug allergies should be administered carefully, and patients with liver function issues should be especially cautious as liver function may deteriorate further. While taking this medication, there is a rare risk of severe allergic reactions such as shock, so symptoms should be monitored closely. Liver function tests may show elevated values, so liver status should be checked carefully. This medication may also affect kidney function, so regular urine tests and kidney function tests are recommended. Blood abnormalities such as anemia may appear, so blood status should be observed. Allergic symptoms such as skin rashes or itching may also occur. Neurological symptoms may include insomnia, drowsiness, headaches, limb paralysis, stiffness, or tremors. Gastrointestinal symptoms may include nausea, vomiting, decreased appetite, abdominal pain, constipation, and diarrhea, so caution is necessary. Urinary symptoms may include difficulty urinating or urinary incontinence. Systemically, symptoms may include weakness, dizziness, and decreased muscle tone, with potential symptoms such as facial flushing, sweating, and swelling. Serious adverse reactions such as anaphylaxis or angioedema have been reported. Particularly, symptoms such as fever, skin rash, blisters, itching, conjunctival injection, and stomatitis may indicate serious skin disorders like toxic epidermal necrolysis syndrome, so the medication should be discontinued immediately, and medical personnel must be informed. During the use of this medication, symptoms such as weakness, dizziness, or drowsiness may occur, so the dosage should be reduced or discontinued if these symptoms arise. Drowsiness may also impair concentration and reflexes, so it is advisable to avoid driving or operating dangerous machinery. This medication may cause side effects such as visual disturbances when taken in conjunction with other muscle relaxants, so caution should be exercised in co-administration. Pregnant women or women who may become pregnant should only take this medication when the benefits of treatment outweigh the risks, as its safety is not established. Nursing women should avoid taking this medication if possible, and if it must be taken, it is advisable to discontinue breastfeeding. Safety in pediatric patients has not been sufficiently established, so care should be taken when administering to children. Elderly patients may have reduced physical function, so caution is advised, including potential dose reduction.

Serious side effects

Shock, elevated ALT, elevated AST, elevated ALP, proteinuria, increased BUN, anemia, anaphylactic reaction, angioedema, toxic epidermal necrolysis and mucocutaneous-ocular syndrome (Stevens-Johnson syndrome)

Mild side effects

• Rash
• itching
• insomnia
• drowsiness
• headache
• limb paralysis
• stiffness of the body
• limb tremors
• nausea
• vomiting

This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. By storing it this way, the medicinal effect can be well maintained.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle